← All industry news

Access matters: Rethinking equity in GLP-1 coverage

coverage_changePublished November 19, 2026

Canadian insurers and employers are reevaluating how GLP-1 medications are covered under group benefits, with growing pressure to ensure equitable access regardless of income or job type.

What happened —

Insurers and employer groups across Canada are reassessing coverage policies for GLP-1 medications, which are increasingly used for weight management and type 2 diabetes. Advocates argue current coverage often excludes lower-wage workers or those in part-time roles, prompting calls for standardized, equitable access across all employee categories.

What it means for consumers —

Employees in non-traditional or lower-income roles may soon see expanded access to GLP-1 drugs if insurers adopt more inclusive benefit designs. Consumers should review their group plan documents and ask HR about coverage eligibility, especially if they’ve previously been denied due to employment status.

What it means for premiums —

No direct premium change has been announced.

Coverage considerations —

Future plans may remove employment-based restrictions, expand formulary inclusion, or introduce tiered co-pays to balance cost and access. Some insurers may also require prior authorization or medical necessity documentation to manage utilization.

Cities affected —

Not specified in source; national policy shift expected.